FDA Notifies Public About Recall Of CBD Product That Tested High For Lead
Summitt quickly moved to get the batch off of shelves
The Food and Drug Administration (FDA) is publicizing a voluntary recall of a CBD product, notifying consumers about potentially high levels of lead in a batch of tinctures that were tested by the Florida Department of Agriculture and Consumer Services.
The federal agency reported on Friday that Summitt Labs, which produces a wide range of hemp-derived cannabidiol products, voluntarily pulled a batch of its Kore Organic watermelon tincture after the state agriculture department conducted a test on a random sample and found high levels of lead, which when ingested can cause various symptoms such as pain, nausea and kidney damage.
The company conducted its own test through an accredited, independent lab that found the lead levels in an acceptable range under state law. But, because the Florida officials found excess lead levels in the sample they tested, Summitt quickly moved to get the batch off of shelves, FDA said. Retailers that carry the product have been notified by phone and email.
To Read The Rest Of This Article On Marijuana Moment, Click Here
